Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study

BACKGROUND: Patient adherence to treatment is key to preventing the worsening of neurological disability in multiple sclerosis (MS). The RebiSmart® autoinjector facilitates self-administration of subcutaneous interferon β-1a (sc IFN β-1a) and records objective adherence data. The CORE study was unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Zecca, Chiara, Disanto, Giulio, Mühl, Sarah, Gobbi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584024/
https://www.ncbi.nlm.nih.gov/pubmed/28870152
http://dx.doi.org/10.1186/s12883-017-0952-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584024/
https://www.ncbi.nlm.nih.gov/pubmed/28870152
http://dx.doi.org/10.1186/s12883-017-0952-9

Ejemplares similares